Cargando…

Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method

PURPOSE: This study aimed to formulate an orally disintegrating tablet (ODT) containing both baclofen and meloxicam together for treating osteoarthritis. METHODS: Direct compression method was used to prepare ODTs using three types of co-processed excipients (Prosolv ODT G2(®), F-melt(®), and Pharma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdelmonem, Rehab, Abdellatif, Menna M, Al-Samadi, Inas Essam Ibrahim, El-Nabarawi, Mohamed A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530526/ https://www.ncbi.nlm.nih.gov/pubmed/34690500 http://dx.doi.org/10.2147/DDDT.S327193

Ejemplares similares

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
por: Chinwala, Maimoona
Publicado: (2020)

The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs)
por: Brniak, Witold, et al.
Publicado: (2015)

Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives
por: Ghourichay, Mohammadali Poursharifi, et al.
Publicado: (2021)

Investigation of Formulation and Process of Lyophilised Orally Disintegrating Tablet (ODT) Using Novel Amino Acid Combination
por: AlHusban, Farhan, et al.
Publicado: (2010)

Puzzle out Machine Learning Model-Explaining Disintegration Process in ODTs
por: Szlęk, Jakub, et al.
Publicado: (2022)

ODT Flow Explorer: Extract, Query, and Visualize Human Mobility
por: Li, Zhenlong, et al.
Publicado: (2020)

Evaluation of Newly Designed and Traditional Punches in Manufacturing of Scored ODTs
por: Palugan, Luca, et al.
Publicado: (2022)

Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study
por: Mahende, Muhidin K., et al.
Publicado: (2021)

Formulation Study of a Co-Processed, Rice Starch-Based, All-in-One Excipient for Direct Compression Using the SeDeM-ODT Expert System
por: Trisopon, Karnkamol, et al.
Publicado: (2021)

ODT FLOW: Extracting, analyzing, and sharing multi-source multi-scale human mobility
por: Li, Zhenlong, et al.
Publicado: (2021)

Utilisation of QSPR ODT modelling and odour vector modelling to predict Cannabis sativa odour
por: Wise, Kimber, et al.
Publicado: (2023)

Lamotrigine ODT-Induced Seizure in a 3-Year-Old Child after Accidental Ingestion
por: Griswold, Ashley, et al.
Publicado: (2019)

Imaging vibrating vocal folds with a high speed 1050 nm swept source OCT and ODT
por: Liu, Gangjun, et al.
Publicado: (2011)

Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation
por: Draksiene, Gailute, et al.
Publicado: (2021)

A Promising Single Oral Disintegrating Tablet for Co-Delivery of Pitavastatin Calcium and Lornoxicam Using Co-Processed Excipients: Formulation, Characterization and Pharmacokinetic Study
por: Teaima, Mahmoud H, et al.
Publicado: (2021)

Assessment of Clinical, Service, and Cost Outcomes of a Conversion Program of Sumatriptan to Rizatriptan ODT in Primary Care Patients With Migraine Headaches
por: Gershovich, Olga E., et al.
Publicado: (2006)

Positive and Negative Syndrome Scale as a long-term outcome measurement tool in patients receiving clozapine ODT- A Pilot Study
por: Shankar, Gollapudi, et al.
Publicado: (2007)

Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation
por: Abdelmonem, Rehab, et al.
Publicado: (2022)

Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG)
por: Yamada, Mizuki, et al.
Publicado: (2022)

Evidence-Based Nanoscopic and Molecular Framework for Excipient Functionality in Compressed Orally Disintegrating Tablets
por: Al-khattawi, Ali, et al.
Publicado: (2014)

Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
por: Qian, Xiaodong, et al.
Publicado: (2022)

Formulation Design of Fast Disintegrating Tablets Using Disintegrant Blends
por: Shirsand, S. B., et al.
Publicado: (2010)

The Use of Capsule Endoscopy to Determine Tablet Disintegration In Vivo
por: Blaabjerg, Lasse I., et al.
Publicado: (2020)

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
por: González-Álvarez, Isabel, et al.
Publicado: (2022)

Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats
por: Fouad, Shahinaze A., et al.
Publicado: (2023)

Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine
por: Musuc, Adina Magdalena, et al.
Publicado: (2021)

Fabrication and In-vitro Evaluation of Buccal Mucoadhesive Tablet of Meloxicam
por: Arabi, Mahshid, et al.
Publicado: (2020)

Development of orally disintegrating tablets containing solid dispersion of a poorly soluble drug for enhanced dissolution: In-vitro optimization/in-vivo evaluation
por: Fouad, Shahinaze A., et al.
Publicado: (2020)

Effect of a Disintegration Mechanism on Wetting, Water Absorption, and Disintegration Time of Orodispersible Tablets
por: Pabari, RM, et al.
Publicado: (2012)

Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study
por: Hassan, Doaa H., et al.
Publicado: (2018)

Determination of drug, excipients and coating distribution in pharmaceutical tablets using NIR-CI
por: Palou, Anna, et al.
Publicado: (2012)

A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
por: Tawfik, Essam A., et al.
Publicado: (2021)

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets
por: Remya, KS, et al.
Publicado: (2010)

Rapid disintegrating tablets of simvastatin dispersions in polyoxyethylene–polypropylene block copolymer for maximized disintegration and dissolution
por: Balata, Gehan F, et al.
Publicado: (2016)

Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets
por: Koner, Jasdip S., et al.
Publicado: (2019)

Digital Image Disintegration Analysis: a Novel Quality Control Method for Fast Disintegrating Tablets
por: Malallah, Osamah, et al.
Publicado: (2021)

Excipient-drug pharmacokinetic interactions: Effect of disintegrants on efflux across excised pig intestinal tissues
por: Gerber, Werner, et al.
Publicado: (2018)

Hordeum Vulgare Hull in the Design of Fast Disintegrating Tablets
por: Rajpurohit, H, et al.
Publicado: (2011)

Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
por: Keny, R. V., et al.
Publicado: (2010)

Fast disintegrating tablets: Opportunity in drug delivery system
por: Parkash, Ved, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ahl6a0ru40esa7t4fpsh67g9lr